Jul 2020 $17 M No. 7 $10 to $50 million 36
AccuVein Inc.: Raise no. 7, Jul 2020 × Investors in this round 36 investors had bought by the notice of Apr 8, 2022: 36 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $17 M of $18 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher Hutchison · Executive Officer, Director Kevin McArdle · Executive Officer Akhilesh Pathipati · Director Brian Verrier · Director Heather Rohan · Director James Lackie · Director Stephen Reeders · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kevin McArdle, Chief Financial Officer. Source: SEC Form D and 2 amendments, newest notice filed Apr 8, 2022. Read the notice at the SEC .
equity SEC Apr 2020 $3 M No. 6 $2 to $10 million 33
AccuVein Inc.: Raise no. 6, Apr 2020 × Investors in this round 33 investors had bought by the notice of May 12, 2020: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Chuck Johnson · Executive Officer Ron Goldman · Executive Officer, Director Christopher Gabrieli · Director Hugo Harrod · Director James Lackie · Director Rudy Mazzochi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ron Goldman, President and Chief Executive Officer. Source: SEC Form D, newest notice filed May 12, 2020. Read the notice at the SEC .
debt, options SEC Oct 2019 $2 M No. 5 $2 to $10 million 33
AccuVein Inc.: Raise no. 5, Oct 2019 × Investors in this round 33 investors had bought by the notice of Nov 15, 2019: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Chuck Johnson · Executive Officer Ron Goldman · Executive Officer, Director Christopher Gabrieli · Director Hugo Harrod · Director James Lackie · Director Rudy Mazzochi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ron Goldman, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 15, 2019. Read the notice at the SEC .
debt, options SEC Jan 2018 $8 M No. 4 $2 to $10 million 40
AccuVein Inc.: Raise no. 4, Jan 2018 × Investors in this round 40 investors had bought by the notice of Feb 12, 2018: 40 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $10 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ron Goldman · Executive Officer, Director Christopher Gabrieli · Director Hugo Harrod · Director James Lackie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ron Goldman, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 12, 2018. Read the notice at the SEC .
equity SEC Sep 2017 $3 M No. 3 $2 to $10 million 11
AccuVein Inc.: Raise no. 3, Sep 2017 × Investors in this round 11 investors had bought by the notice of Jan 2, 2018: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ron Goldman · Executive Officer, Director Christopher Gabrieli · Director Frank Flaunt III · Director Hugo Harrod · Director James Lackie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Amounts invested in three (3) closings.”Signed by Ron Goldman, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 2, 2018. Read the notice at the SEC .
debt, options SEC Nov 2016 $2 M No. 2 $2 to $10 million 28
AccuVein Inc.: Raise no. 2, Nov 2016 × Investors in this round 28 investors had bought by the notice of Dec 2, 2016: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $9 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ron Goldman · Executive Officer, Director Christopher Gabrieli · Director Eric Bednarski · Director Frank Flaut III · Director James Lackie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ron Goldman, President and CEO. Source: SEC Form D, newest notice filed Dec 2, 2016. Read the notice at the SEC .
debt, options SEC Jul 2011 $23 M No. 1 $10 to $50 million 62
AccuVein Inc.: Raise no. 1, Jul 2011 × Investors in this round 62 investors had bought by the notice of Oct 27, 2011: 62 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $23 M of $23 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,560,000
Finders' fees none
Paid to its own people $423,117 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Joseph Anthony McCormick · Executive Officer Joseph Anthony Zott · Executive Officer Ron Goldman · Executive Officer, Director Vincent Anthony Luciano · Executive Officer Christopher Anthony Gabrieli · Director Eric Anthony Bednarski · Director Frank Lee Flautt III · Director James Donald Lackie · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Aquilo Partners, L.P. (CRD 114909) · San Francisco, California Sold in CA, CT, IL, MA, NY, OH, PA, TX, UT, WA Remarks in the notice On the use of proceeds: “Repayment of loans made by two directors and one officer”Signed by Ron Goldman, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Oct 27, 2011. Read the notice at the SEC .
equity SEC